US EditionMedTech Innovator Unveils 65 Breakthrough Medtech Startups in Its 2025 Cohort
- MedTech Innovator announced its 2025 Accelerator Cohort on June 6, selecting 65 top startups from nearly 1,500 global applicants.
- The cohort was selected through a competitive process that included 213 company presentations and evaluations by 430 experts during Road Tour gatherings held in Los Angeles, College Park, Maryland, and Dublin.
- The startups will engage in a four-month program focused on fast-tracking access to the U.S. Market and benefit from MTI's network and funding opportunities.
- Participants compete for $800,000 in non-dilutive funding while working closely with mentors and partners in areas like diagnostics, neurology, and cardiovascular health.
- This program aims to mitigate risks and create value by helping medtech innovators bring disruptive solutions to public health and market access.
Insights by Ground AI
Does this summary seem wrong?
34 Articles
34 Articles
All
Left
4
Center
12
Right
2
Equity research firms see upside for medtech Compumedics
Two equity research firms endorse Compumedics and see upside to share price Recent FDA clearance for its next-generation home sleep tests set to open lucrative new market Neuroscan Orion LifeSpan magnetoencephalography system also provides opportunity to boost revenue Special Report: Compumedics has received endorsements from two equity research firms — East Coast Research and PAC Partners— both of which see upside potential in the company’s s…
Coverage Details
Total News Sources34
Leaning Left4Leaning Right2Center12Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 22%
C 67%
11%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
